GENEDRIVE PLC — AGM Information 2017

Nov 29, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8820X

Genedrive PLC

29 November 2017

For release: 29 November 2017

genedrive plc ("genedrive" or the "Company")

Result of AGM

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held in Manchester today, all resolutions proposed were duly passed.

-  Ends  -

For further details please contact:

genedrive plc	+44 (0)161 989 0245
David Budd: CEO
Matthew Fowler: CFO
Peel Hunt LLP	+44 (0)207 418 8900
James Steel
Oliver Jackson
Consilium Strategic Communications	+44 (0)203 709 5700
Chris Gardner
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.

Further details can be found at: www.genedriveplc.com and www.genedrive.com 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGBSBDBUBDBGRC